Green Cross Medical Science Corporation (KOSDAQ:142280)

South Korea · Delayed Price · Currency is KRW

3,810.00

+15.00 (0.40%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Green Cross MS Co., Ltd.	104.60B	94.07B	110.82B	100.83B	110.99B
Green Cross MS Co., Ltd. Growth	11.20%	-15.12%	9.91%	-9.16%	36.20%
Green Cross Medis Co., Ltd.	13.16B	11.76B	14.88B	12.79B	12.87B
Green Cross Medis Co., Ltd. Growth	11.97%	-21.02%	16.38%	-0.62%	31.97%
Consolidated Adjustments	-13.91B	-11.81B	-12.60B	-11.94B	-10.48B
Total	103.85B	94.01B	113.11B	101.67B	113.38B
Total Growth	10.47%	-16.88%	11.25%	-10.32%	39.13%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Overseas	7.80B	6.02B	12.00B	16.56B	25.15B
Overseas Growth	29.60%	-49.83%	-27.57%	-34.16%	284.93%
South Korea	96.05B	87.99B	101.11B	85.11B	88.22B
South Korea Growth	9.16%	-12.98%	18.80%	-3.53%	17.70%
Total	103.85B	94.01B	113.11B	101.67B	113.38B
Total Growth	10.47%	-16.88%	11.25%	-10.32%	39.13%

Source: S&P Global Market Intelligence.